“…Several studies, including a meta‐analysis, have reported the prognostic utility of the NLR, LMR, PLR, PNI, and HS‐mGPS in head and neck cancers. 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 Regarding previous reports on a systematic review and meta‐analysis, Yang et al 22 investigated a total of 25 studies and demonstrated that higher pretreatment NLR was associated with poorer prognosis. Takenaka et al 23 reviewed 19 studies of head and neck cancer and showed that an elevated pretreatment NLR had a predictive value of poorer OS and DSS.…”